60.89Down-0.48-0.78%Today's Close  |  60.89 unch unch After hours
Find StockScouter ratings for:
BIOMARIN PHARMACEUTICALS INC: STOCK RATING SUMMARY
4
StockScouter

BIOMARIN PHARMACEUTICALS INC, a mid-cap growth company in the health care sector, is expected to underperform the market over the next six months with above average risk.

10 is the best possible rating.

QUICK SUMMARY
Pro

The price-to-sales multiple is significantly higher than the average for all stocks in the StockScouter universe. Very positive for a medium- to large-sized company like BMRN

Previous day’s closing price for BMRN was significantly below its 50-day moving average, a level from which prices frequently rebound over the long term. Positive

Con

The most recent quarterly earnings report was significantly lower than analysts' consensus forecast. Negative

The price-to-earnings multiple is a negative number. No effect

FUNDAMENTAL
Grade: F

The most recent quarterly earnings report was significantly lower than analysts' consensus forecast. Negative

Earnings growth in the past year has decelerated moderately compared to earnings growth in the past three years. Negative

One or more analysts has modestly decreased quarterly earnings estimates for BMRN. Negative

OWNERSHIP
Grade: D

Two or more executives, directors or major shareholders sold a small number of shares recently. Negative

Shares are neither being accumulated heavily nor sold heavily by financial institutions. Neutral for a large company like BMRN

VALUATION
Grade: B

The price-to-earnings multiple is a negative number. No effect

The price-to-sales multiple is significantly higher than the average for all stocks in the StockScouter universe. Very positive for a medium- to large-sized company like BMRN

The ratio of BMRN's price-to-earnings multiple to its five-year growth rate is unavailable or inconsistent.

TECHNICAL
Grade: C

The StockScouter measure of relative price change and consistency is low. Negative

Previous day’s closing price for BMRN was significantly below its 50-day moving average, a level from which prices frequently rebound over the long term. Positive

StockScouter data provided by Verus Analytics

Verus Analytics, Inc.

Learn more about the StockScouter rating system.

Page generated 4/19/2014 1:16 PM ET

DATA PROVIDERS

Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.